Disruption of response inhibition circuits in prodromal Huntington disease

Cortex

Volumn 58, Issue , 2014, Pages 72-85

  Rao, Julia A ^a   Harrington, Deborah L ^b,c   Durgerian, Sally ^d   Reece, Christine ^e   Mourany, Lyla ^e   Koenig, Katherine ^e   Lowe, Mark J ^e   Magnotta, Vincent A ^f   Long, Jeffrey D ^f   Johnson, Hans J ^f   Paulsen, Jane S ^f   Rao, Stephen M ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

Brain activation; Brain atrophy; FMRI; Huntington's disease; Neuropsychological testing; Response inhibition

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; ATTENTION; BRAIN CORTEX ATROPHY; BRAIN SIZE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); EXECUTIVE FUNCTION; EXPERIMENTAL COGNITIVE TEST; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; IMAGING SOFTWARE; INFERIOR FRONTAL GYRUS; INFERIOR PARIETAL LOBULE; INHIBITION (PSYCHOLOGY); INSULA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR CONTROL; NUCLEAR MAGNETIC RESONANCE SCANNER; RESPONSE INHIBITION; RIGHT HEMISPHERE; STOP SIGNAL TASK; SUPPLEMENTARY MOTOR AREA; TASK PERFORMANCE; TEMPORAL CORTEX; VENTRAL ATTENTION NETWORK; YOUNG ADULT; BRAIN; BRAIN MAPPING; COGNITION; IMAGE PROCESSING; NERVE CELL NETWORK; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; ATTENTION; BRAIN; BRAIN MAPPING; COGNITION; EXECUTIVE FUNCTION; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE NET; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84904621662     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2014.04.018     Document Type: Article

References (67)

1. Andresen J.M., Gayan J., Djousse L., Roberts S., Brocklebank D., Cherny S.S., et al. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Annals of Human Genetics 2007, 71(Pt 3):295-301. 10.1111/j.1469-1809.2006.00335.x.
2. Aron A.R. From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biological Psychiatry 2011, 69:e55-e68.
3. Aron A.R., Poldrack R.A. Cortical and subcortical contributions to stop signal response inhibition: role of the subthalamic nucleus. Journal of Neuroscience 2006, 26(9):2424-2433. 10.1523/JNEUROSCI.4682-05.2006.
4. Aron A.R., Schlaghecken F., Fletcher P.C., Bullmore E.T., Eimer M., Barker R., et al. Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease. Brain: A Journal of Neurology 2003, 126(Pt 3):713-723.
5. Beste C., Ness V., Falkenstein M., Saft C. On the role of fronto-striatal neural synchronization processes for response inhibition-evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers. Neuropsychologia 2011, 49(12):3484-3493. 10.1016/j.neuropsychologia.2011.08.024.
6. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Response inhibition in Huntington's disease-a study using ERPs and sLORETA. Neuropsychologia 2008, 46(5):1290-1297. 10.1016/j.neuropsychologia.2007.12.008.
7. Beste C., Willemssen R., Saft C., Falkenstein M. Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. Neuropsychologia 2010, 48(2):366-373. 10.1016/j.neuropsychologia.2009.09.023.
8. Boehler C.N., Appelbaum L.G., Krebs R.M., Hopf J.M., Woldorff M.G. Pinning down response inhibition in the brain-conjunction analyses of the stop-signal task. NeuroImage 2010, 52(4):1621-1632. 10.1016/j.neuroimage.2010.04.276.
9. Celone K.A., Calhoun V.D., Dickerson B.C., Atri A., Chua E.F., Miller S.L., et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. Journal of Neuroscience 2006, 26(40):10222-10231. pii: 26/40/10222. 10.1523/JNEUROSCI.2250-06.2006.
10. Chiou S.Y., Wang R.Y., Liao K.K., Wu Y.T., Lu C.F., Yang Y.R. Co-activation of primary motor cortex ipsilateral to muscles contracting in a unilateral motor task. Clinical Neurophysiology 2013, 124:1353-1363.
11. Congdon E., Mumford J.A., Cohen J.R., Galvan A., Aron A.R., Xue G., et al. Engagement of large-scale networks is related to individual differences in inhibitory control. NeuroImage 2010, 53(2):653-663. pii: S1053-8119(10)00920-1. 10.1016/j.neuroimage.2010.06.062.
12. Corbetta M., Patel G., Shulman G.L. The reorienting system of the human brain: from environment to theory of mind. Neuron 2008, 58(3):306-324. pii: S0896-6273(08)00369-3. 10.1016/j.neuron.2008.04.017.
13. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nature Reviews Neuroscience 2002, 3(3):201-215.
14. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research, an International Journal 1996, 29(3):162-173.
15. Derosiere G., Alexandre F., Bourdillon N., Mandrick K., Ward T.E., Perrey S. Similar scaling of contralateral and ipsilateral cortical responses during graded unimanual force generation. NeuroImage 2014, 85(Pt 1):471-477.
16. Desikan R.S., Cabral H.J., Hess C.P., Dillon W.P., Glastonbury C.M., Weiner M.W., et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 2009, 132(Pt 8):2048-2057. Alzheimer's Disease Neuroimaging, I. 10.1093/brain/awp123.
17. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 2006, 31(3):968-980. 10.1016/j.neuroimage.2006.01.021.
18. Duff K., Paulsen J., Mills J., Beglinger L.J., Moser D.J., Smith M.M., et al. Mild cognitive impairment in prediagnosed Huntington disease. Neurology 2010, 75(6):500-507. 10.1212/WNL.0b013e3181eccfa2.
19. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genetics 1993, 4(4):387-392. 10.1038/ng0893-387.
20. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(20):11050-11055. 10.1073/pnas.200033797.
21. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., et al. Automatically parcellating the human cerebral cortex. Cerebral Cortex 2004, 14(1):11-22.
22. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Transactions on Medical Imaging 2001, 20(1):70-80. 10.1109/42.906426.
23. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
24. Georgiou-Karistianis N., Farrow M., Wilson-Ching M., Churchyard A., Bradshaw J.L., Sheppard D.M. Deficits in selective attention in symptomatic Huntington disease: assessment using an attentional blink paradigm. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology 2012, 25(1):1-6. 10.1097/WNN.0b013e318248c503.
25. Golden C.J., Freshwater S.M. Stroop color and word test: Revised examiner's manual 2002, Stoelting Co, Wood Dale, IL.
26. Gray M.A., Egan G.F., Ando A., Churchyard A., Chua P., Stout J.C., et al. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study. Experimental Neurology 2013, 239:218-228. pii: S0014-4886(12)00403-7. 10.1016/j.expneurol.2012.10.020.
27. Hacker C.D., Perlmutter J.S., Criswell S.R., Ances B.M., Snyder A.Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012, 135(Pt 12):3699-3711. pii: aws281. 10.1093/brain/aws281.
28. Hampshire A., Chamberlain S.R., Monti M.M., Duncan J., Owen A.M. The role of the right inferior frontal gyrus: inhibition and attentional control. NeuroImage 2010, 50(3):1313-1319. 10.1016/j.neuroimage.2009.12.109.
29. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 2006, 32(1):180-194. 10.1016/j.neuroimage.2006.02.051.
30. Harrington D.L., Liu D., Smith M.M., Mills J.A., Long J.D., Aylward E.H., et al. Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease. Brain and Behavior 2014, 4(1):28-40. doi: 10.1002Jbrb3.18S.
31. Harrington D.L., Smith M.M., Zhang Y., Carlozzi N.E., Paulsen J.S. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83(6):612-619. 10.1136/jnnp-2011-301732.
32. Henderson T., Georgiou-Karistianis N., White O., Millist L., Williams D.R., Churchyard A., et al. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease. Movement Disorders: Official Journal of the Movement Disorder Society 2011, 26(10):1893-1899. 10.1002/mds.23757.
33. HSG Unified Huntington's disease rating scale: reliability and consistency. Movement Disorders 1996, 11:136-142.
34. Jech R., Mueller K., Schroeter M.L., Ruzicka E. Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson's disease. Brain 2013, 136:e234.
35. Levy B.J., Wagner A.D. Cognitive control and right ventrolateral prefrontal cortex: reflexive reorienting, motor inhibition, and action updating. Annals of the New York Academy of Sciences 2011, 1224:40-62. 10.1111/j.1749-6632.2011.05958.x.
36. Li C.S., Huang C., Constable R.T., Sinha R. Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing. The Journal of Neuroscience 2006, 26:186-192.
37. Majid D.S., Cai W., Corey-Bloom J., Aron A.R. Proactive selective response suppression is implemented via the basal ganglia. Journal of Neuroscience 2013, 33(33):13259-13269. 10.1523/JNEUROSCI.5651-12.2013.
38. Matsui J.T., Vaidya J.G., Johnson H.J., Magnotta V.A., Long J.D., Mills J.A., et al. Diffusion weighted imaging of prefrontal cortex in prodromal huntington's disease. Human Brain Mapping 2014, 35:1562-1573.
39. Menon V., Uddin L.Q. Saliency, switching, attention and control: a network model of insula function. Brain Structure & Function 2010, 214(5-6):655-667. 10.1007/s00429-010-0262-0.
40. Merchant H., Harrington D.L., Meck W.H. Neural basis of the perception and estimation of time. Annual Review of Neuroscience 2013, 36.
41. Nopoulos P.C., Aylward E.H., Ross C.A., Johnson H.J., Magnotta V.A., Juhl A.R., et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiology of Disease 2010, 40(3):544-554. 10.1016/j.nbd.2010.07.014.
42. Novak M.J., Warren J.D., Henley S.M., Draganski B., Frackowiak R.S., Tabrizi S.J. Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain 2012, 135(Pt 4):1165-1179. pii: aws024. 10.1093/brain/aws024.
43. O'Rourke J.J., Beglinger L.J., Smith M.M., Mills J., Moser D.J., Rowe K.C., et al. The trail making test in prodromal Huntington disease: contributions of disease progression to test performance. Journal of Clinical and Experimental Neuropsychology 2011, 33(5):567-579. 10.1080/13803395.2010.541228.
44. Paulsen J.S., Hayden M., Stout J.C., Langbehn D.R., Aylward E., Ross C.A., et al. Preparing for preventive clinical trials: the Predict-HD study. Archives of Neurology 2006, 63(6):883-890. Predict, H. D. I. o. t. H. S. G. 10.1001/archneur.63.6.883.
45. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., et al. Detection of Huntington's disease decades before diagnosis: the predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79(8):874-880. 10.1136/jnnp.2007.128728.
46. Paulsen J.S., Smith M.M., Long J.D. Cognitive decline in prodromal Huntington Disease: implications for clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 2013, 84(11):1233-1239.
47. Paulsen J.S., Zhao H., Stout J.C., Brinkman R.R., Guttman M., Ross C.A., et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001, 57(4):658-662. Huntington Study, G.
48. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol 2004, 25(10):1715-1721.
49. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 1997, 41(5):689-692. 10.1002/ana.410410521.
50. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., et al. Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology 2004, 55(6):879-883. 10.1002/ana.20121.
51. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills 1958, 8:271-276.
52. Reuter M., Schmansky N.J., Rosas H.D., Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage 2012, 61(4):1402-1418. 10.1016/j.neuroimage.2012.02.084.
53. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005, 65(5):745-747. 10.1212/01.wnl.0000174432.87383.87.
54. Rubia K., Russell T., Overmeyer S., Brammer M.J., Bullmore E.T., Sharma T., Simmons A., Williams S.C., Giampietro V., Andrew C.M., Taylor E. Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 2001, 13:250-261.
55. Rushworth M.F., Krams M., Passingham R.E. The attentional role of the left parietal cortex: the distinct lateralization and localization of motor attention in the human brain. Journal of Cognitive Neuroscience 2001, 13(5):698-710.
56. Smith A. Symbol digit modalities test 1991, Western Psychological Services, Los Angeles, CA.
57. Stout J.C., Paulsen J.S., Queller S., Solomon A.C., Whitlock K.B., Campbell J.C., et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011, 25(1):1-14. 10.1037/a0020937.
58. Swerdlow N.R., Paulsen J.S., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry 1995, 58:192-200.
59. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the human brain 1988, Thieme, New York.
60. Tobin A.J., Signer E.R. Huntington's disease: the challenge for cell biologists. Human Brain Mapping 2000, 10(12):531-536. pii: S0962-8924(00)01853-5.
61. Vonsattel J.P., DiFiglia M. Huntington disease. Journal of Neuropathology and Experimental Neurology 1998, 57(5):369-384.
62. Wolf R.C., Gron G., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., et al. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Human Brain Mapping 2012, 33(9):2161-2173. 10.1002/hbm.21348.
63. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Experimental Neurology 2008, 213(1):137-144. 10.1016/j.expneurol.2008.05.017.
64. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain: A Journal of Neurology 2007, 130(Pt 11):2845-2857. 10.1093/brain/awm210.
65. Zhang S., Li C.R. Functional networks for cognitive control in a stop signal task: independent component analysis. Human Brain Mapping 2012, 33:89-104.
66. Zhang Y., Long J.D., Mills J.A., Warner J.H., Lu W., Paulsen J.S. Indexing disease progression at study entry with individuals at-risk for Huntington disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2011, 156B(7):751-763. 10.1002/ajmg.b.31232.
67. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 2007, 13(5):758-769. 10.1017/S1355617707071214.